Literature DB >> 23162025

The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinoma.

Stefano Crippa1, Piercarlo Saletti, Jessica Barizzi, Luca Mazzucchelli.   

Abstract

Papillary thyroid carcinoma is an extraintestinal manifestation of patients with familial adenomatous polyposis, mainly occurring in young women. Recent publications highlight that familial adenomatous polyposis-associated papillary thyroid carcinoma represents a distinct type of follicular cell neoplasm histologically characterised by cribriform-morular aspects, the incidence of which has probably been underestimated so far. We report a case history of familial adenomatous polyposis-associated papillary thyroid carcinoma occurring in a 55-year-old man with Gardner syndrome, underscoring the importance of careful ultrasound screening examination of the thyroid gland in this condition.

Entities:  

Mesh:

Year:  2012        PMID: 23162025      PMCID: PMC4543772          DOI: 10.1136/bcr-2012-007046

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?

Authors:  J Cameselle-Teijeiro; J K Chan
Journal:  Mod Pathol       Date:  1999-04       Impact factor: 7.842

2.  Case records of the Massachusetts General Hospital. Case 37-2006. A 19-year-old woman with thyroid cancer and lower gastrointestinal bleeding.

Authors:  Daniel C Chung; Michael M Maher; William C Faquin
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

3.  Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.

Authors:  Maite Herraiz; Giuseppe Barbesino; William Faquin; Gayun Chan-Smutko; Devanshi Patel; Kristen M Shannon; Gilbert H Daniels; Daniel C Chung
Journal:  Clin Gastroenterol Hepatol       Date:  2007-01-26       Impact factor: 11.382

4.  Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients.

Authors:  Yasuhiro Ito; Akira Miyauchi; Hideki Ishikawa; Mitsuhiro Hirokawa; Takumi Kudo; Chisato Tomoda; Akihiro Miya
Journal:  Endocr J       Date:  2011-06-14       Impact factor: 2.349

Review 5.  Familial thyroid cancer: a review.

Authors:  Vânia Nosé
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

Review 6.  Familial adenomatous polyposis associated thyroid carcinoma: a distinct type of follicular cell neoplasm.

Authors:  H R Harach; G T Williams; E D Williams
Journal:  Histopathology       Date:  1994-12       Impact factor: 5.087

7.  (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology.

Authors:  Luca Giovanella; Sergio Suriano; Marco Maffioli; Luca Ceriani; Giuseppe Spriano
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

Review 8.  Familial non-medullary thyroid carcinoma: an update.

Authors:  Vânia Nosé
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 9.  Familial thyroid carcinoma: a diagnostic algorithm.

Authors:  Jorge Dotto; Vânia Nosé
Journal:  Adv Anat Pathol       Date:  2008-11       Impact factor: 3.875

10.  Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study.

Authors:  C Soravia; S L Sugg; T Berk; A Mitri; H Cheng; S Gallinger; Z Cohen; S L Asa; B V Bapat
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more
  1 in total

1.  Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D.

Authors:  Taina T Nieminen; Christopher J Walker; Alisa Olkinuora; Luke K Genutis; Margaret O'Malley; Paul E Wakely; Lisa LaGuardia; Laura Koskenvuo; Johanna Arola; Anna H Lepistö; Pamela Brock; Ayse Selen Yilmaz; Ann-Kathrin Eisfeld; James M Church; Päivi Peltomäki; Albert de la Chapelle
Journal:  Thyroid       Date:  2020-03       Impact factor: 6.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.